Beijing PCTech Pharmaceutical Technology

Beijing PCTech Pharmaceutical Technology is a biotechnology company specializing in the development of long-acting drug delivery systems through its proprietary PEGylation technology platform. Based in Beijing, the company provides high-purity polyethylene glycol (PEG) derivatives and comprehensive CDMO services for the modification of proteins, peptides, and small molecules. PCTech's technology aims to enhance the pharmacokinetic properties of therapeutics by increasing solubility, reducing immunogenicity, and extending half-life. The company has a robust internal and partnered pipeline, including a commercialized long-acting Granulocyte Colony-Stimulating Factor (PEG-G-CSF) and several candidates in clinical trials for infectious diseases and oncology. Their expertise in site-specific conjugation has established them as a leader in the Chinese long-acting drug market.